The UroLift procedure is a minimally invasive treatment for benign prostatic hyperplasia (BPH), a condition where the prostate gland enlarges and causes urinary symptoms in men.
During the UroLift procedure, small implants are placed in the prostate to lift and hold the enlarged tissue away from the urethra. This helps to open up the urinary passage and improve urine flow. The implants are made of tiny metal clips and sutures, and they act like curtains that hold the prostate lobes in a lifted position.
The procedure is typically performed under local or general anesthesia. The doctor uses a small scope called a cystoscope to access the prostate through the urethra. With the help of specialized tools, the doctor places the UroLift implants at strategic locations in the prostate, ensuring that they do not block the ejaculatory ducts or interfere with sexual function.
The UroLift procedure is considered minimally invasive because it does not involve removing or cutting any prostate tissue. It is generally performed as an outpatient procedure, meaning that patients can usually go home the same day. Recovery time is typically shorter compared to traditional surgical options for BPH.
After the procedure, patients may experience some temporary side effects such as mild discomfort, urinary frequency, or urgency. However, these symptoms usually resolve within a few days to weeks.
The UroLift procedure has been shown to effectively relieve urinary symptoms caused by BPH while preserving sexual function. It provides an alternative treatment option for men seeking relief from bothersome urinary symptoms without the need for more invasive surgery.